Acetylcholinesterase inhibitors from plants
Pulok K Mukherjee1, Venkatesan Kumar, Mainak Mal
1Department of Pharmacy, Pharmacognosy Research Laboratories, Franklin-Wilkins Building, King's College London, 150 Stamford Street, London SE1 9NH, UK. pulokm@gmail.com
Nature provides promising plant-based acetylcholinesterase (AChE) inhibitors for neurological disorders like Alzheimer's disease. This review surveys plants with AChE inhibitory activity, highlighting key phytoconstituents and species.
Area of Science:
- Pharmacology
- Ethnobotany
- Neuroscience
Background:
- Acetylcholinesterase (AChE) is crucial for acetylcholine breakdown.
- AChE inhibition is a therapeutic strategy for Alzheimer's disease and other neurological disorders.
- Natural products, particularly plants, are a rich source of potential AChE inhibitors.
Purpose of the Study:
- To conduct a comprehensive literature survey of plants exhibiting AChE inhibitory activity.
- To identify promising plant species and their constituent compounds with AChE inhibitory potential.
- To consolidate current knowledge on ethnobotanical sources for AChE inhibitors.
Main Methods:
- Literature search for studies reporting plant-based AChE inhibition.
- Compilation and analysis of reported plant species and their inhibitory effects.
- Identification of key phytoconstituents responsible for AChE inhibition.
Main Results:
- Numerous plant species have demonstrated significant AChE inhibitory activity.
- Various phytoconstituents from these plants show potential as AChE inhibitors.
- This review highlights specific plants and compounds warranting further investigation.
Conclusions:
- Plants represent a valuable and largely untapped resource for developing novel AChE inhibitors.
- Further research into plant-derived compounds could lead to new treatments for neurological conditions.
- Ethnobotanical knowledge is key to discovering effective AChE-inhibiting agents.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
